ClinicalTrials.Veeva

Menu
R

Red Oak Psychiatry Associates | Houston, TX

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Cariprazine
Lumateperone
PRC-063
SPD489
SHP465
Aticaprant
L1-79
BMS-820836
Fluoxetine
Seltorexant

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 22 total trials

A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder. (3112 Ped BPD)

Bipolar disorder is a severe chronic mood disorder that affects up to 4% of the adult population and 1.8% of the pediatric population in the United S...

Enrolling
Bipolar I Disorder
Depression
Drug: Placebo
Drug: Cariprazine
Locations recently updated

This is a multicenter, randomized, double-blind, placebo-controlled study in pediatric patients who are experiencing major depressive episodes (MDEs)...

Enrolling
Bipolar Depression
Drug: Lumateperone
Drug: Placebo

This is a multicenter, randomized, double-blind, placebo-controlled study in pediatric patients aged 5 to 17 years with a primary diagnosis of irrita...

Enrolling
Irritability Associated With Autism Spectrum Disorder
Drug: Lumateperone low dose
Drug: Lumateperone high dose

This is a multicenter, global, 26-week, open-label study to assess the safety and tolerability of lumateperone in pediatric patients with schizophren...

Enrolling
Autism Spectrum Disorder
Schizophrenia
Drug: Lumateperone

Trial sponsors

AbbVie logo
Intra-Cellular Therapies logo
R
Shire logo
Janssen (J&J Innovative Medicine) logo
Bristol-Myers Squibb (BMS) logo
Forest Laboratories logo
N
N
S

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems